• Careers
  • Investors
  • News
  • Partnering
  • Contact Us
 
  • Home
  • Our Products
    • Recent Products
    • Consumer Products
    • Medical Devices & Diagnostics
    • Prescription Products
    • Product Coupons
  • Our Caring
    • Our Stories
    • Our Giving
    • Our Responsibility
    • Protecting Our People
    • Company Initiatives
  • Our Company
    • Our Credo Values
    • Our Management Approach
    • Our Citizenship
    • Corporate Governance
    • Company Structure
    • Our People & Diversity
    • Company Publications
    • Our History
  • News
    • All News
    • Corporate News
    • Product And Operating Company News
    • Financial News
    • Media Contacts
    • All News Archive
  • Text Size
  • Text Only
  • Email to a Friend
  • Printer Friendly
  • RSS

All News

Find press releases issued in the past two years issued by Johnson & Johnson corporate headquarters and our operating companies.

< Prev | | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | .... 39 Next >
Janssen and Johnson & Johnson to Provide Webcast Presentation of Immunology Pivotal Phase 3 Data Being Presented at the American College of Rheumatology Annual Meeting

November 02, 2012

Johnson & Johnson Postpones Medical Devices & Diagnostics Review

October 30, 2012

Johnson & Johnson to Host Medical Devices & Diagnostics Review

October 25, 2012

Johnson & Johnson’s Wellness & Prevention, Inc. and Lake Nona Institute Join Forces to Create Measurable Health and Wellness Community Program

October 23, 2012

SAPPHIRE Worldwide Study Data Presented at TCT 2012 Study demonstrates benefit of Carotid Artery Stenting in Symptomatic and Asymptomatic Patients at High Risk of Surgery

October 23, 2012

New One-Year Phase 3 Study Results Show Anti-Tnf SIMPONI® Maintained Clinical Response In Treatment Of Moderately To Severely Active Ulcerative Colitis

October 22, 2012

< Prev | | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | .... 39 Next >
  • Accessibility
  • Sitemap
  • Privacy Policy
  • Legal Notice
  • Employees
This site is governed solely by applicable U.S. laws and governmental regulations. Please see our Privacy Policy. Use of this site constitutes your consent to application of such laws and regulations and to our Privacy Policy. Your use of the information on this site is subject to the terms of our Legal Notice. You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson Services, Inc. Contact Us with any questions or search this site for more information.
All contents © Copyright Johnson & Johnson Services, Inc.1997-2013. All Rights Reserved.
  • Find us at
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • Employees
  • Careers
  • Investors
  • News
  • Partnering
  • Contact Us
Johnson & Johnson
  • Home
  • Our Products
  • Our Caring
  • Our Company
  • All News
  • Corporate News
  • Product And Operating Company News
  • Financial News
  • Media Contacts
  • All News Archive
  • Text Size
  • Graphic Version
  • Email to a Friend
  • Printer Friendly
  • RSS

All News

Find press releases issued in the past two years issued by Johnson & Johnson corporate headquarters and our operating companies.

< Prev | | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | .... 39 Next >
Janssen and Johnson & Johnson to Provide Webcast Presentation of Immunology Pivotal Phase 3 Data Being Presented at the American College of Rheumatology Annual Meeting

November 02, 2012

Johnson & Johnson Postpones Medical Devices & Diagnostics Review

October 30, 2012

Johnson & Johnson to Host Medical Devices & Diagnostics Review

October 25, 2012

Johnson & Johnson’s Wellness & Prevention, Inc. and Lake Nona Institute Join Forces to Create Measurable Health and Wellness Community Program

October 23, 2012

SAPPHIRE Worldwide Study Data Presented at TCT 2012 Study demonstrates benefit of Carotid Artery Stenting in Symptomatic and Asymptomatic Patients at High Risk of Surgery

October 23, 2012

New One-Year Phase 3 Study Results Show Anti-Tnf SIMPONI® Maintained Clinical Response In Treatment Of Moderately To Severely Active Ulcerative Colitis

October 22, 2012

< Prev | | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | .... 39 Next >
  • Accessibility
  • Sitemap
  • Privacy Policy
  • Legal Notice
  • Employees
This site is governed solely by applicable U.S. laws and governmental regulations. Please see our Privacy Policy. Use of this site constitutes your consent to application of such laws and regulations and to our Privacy Policy. Your use of the information on this site is subject to the terms of our Legal Notice. You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson Services, Inc. Contact Us with any questions or search this site for more information.
All contents © Copyright Johnson & Johnson Services, Inc.1997-2013. All Rights Reserved.
  • Find us at
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •